Rethinking why we don’t have a cure for Alzheimer’s
By Janet McMillan, C2ST volunteer and graduate student in chemistry at Northwestern University
For anyone who watches the nightly news on a regular basis, it would seem that one massive medical breakthrough after another has resulted in countless drugs available to cure Alzheimer’s disease. These massively overstated headlines often fail to report that the drug in question has not yet demonstrated efficacy in improving memory in late stage clinical trails. Again and again, a promising drug that can cure Alzheimer’s in mice fails to produce positive results in clinical trails. Despite the large number of drug candidates making it to this point in the past few years, the only drug on the market currently, Mermantine, only produces short term memory benefits for patients. Dr. Grace Stutzmann, an Associate Professor in the Department of Neuroscience at Rosalind Franklin University tries to understand why so many of these drugs are failing to do what scientists think they will.
Continue reading “Rethinking why we don’t have a cure for Alzheimer’s”